Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
CheckMate 77T Trial: Perioperative Nivolumab Plus Chemotherapy in Stage ...
CheckMate 77T Biomarker Analysis Highlights ctDNA and Genomic Signals ...
FDA Approval: Perioperative Nivolumab + Chemotherapy - CheckMate 77T ...
CheckMate 77T QOL Data Further Support Perioperative Nivolumab in ...
CheckMate 77T Trial of Perioperative Nivolumab Generates EFS Benefit in ...
WCLC 2024 | Nivolumab's Perk in Perioperative NSCLC: CheckMate 77T ...
MEDtalks | CheckMate 77T fase III: Neoadjuvant nivolumab plus ...
ASCO 2025: CheckMate 77T Shows EFS Benefit With Perioperative Nivolumab ...
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial | AJMC
Perioperative nivolumab safe for early-stage NSCLC: CheckMate 77T ...
CheckMate 77T Analysis Evaluates Perioperative Nivolumab in Resectable ...
Full results and Plain Language Summary for CheckMate 77T trial - NEJM ...
According to CheckMate 77T study, for patients with an early stage of ...
Checkmate 77T: Perioperative chemoimmunotherapy outperforms in early ...
CheckMate 77T: Nivolumab Preserves Quality of Life and Mitigates Symptom
Checkmate 77T: Perioperative Nivolumab in NSCLC - OncTalk Lung 2023 ...
CheckMate 8HW Trial at ASCO 2025: Nivolumab Plus Ipilimumab Sets New ...
CheckMate 214 Trial Final 9-Year Results at ASCO 2025: Nivolumab Plus ...
CheckMate 77T, LAURA trial, nivolumab, osimertinib, EGFR
Nivolumab Enhances Event-Free Survival in Resectable NSCLC in CheckMate ...
LBA1 CheckMate 77T: Phase III study comparing neoadjuvant nivolumab ...
切除可能NSCLCへのニボルマブ、術前術後vs.術前（CheckMate 77T vs.816）／WCLC2024｜医師向け医療ニュースはケアネット
2025 ASCO | CheckMate 816/77T双研究夯实纳武利尤单抗肺癌围术期治疗地位，实现生存获益到精准分层的突破 - 知乎
CheckMate 77T第3相｜周術期のニボルマブが切除可能NSCLCのEFSを改善
CheckMate 77T: Updated Survival and Biomarker Insights Shaping Early ...
CheckMate 8HW: Nivolumab + Ipilimumab Improves PFS in dMMR/MSI-H CRC ...
CheckMate-77T ｜术前术后应用纳武利尤单抗降低NSCLC术后复发风险_患者_化疗_治疗
Clinical outcomes with perioperative nivolumab by nodal status in ...
切除可能肺がんにおけるNivolumab周術期治療(CheckMate-77T)｜ruteth
ALK-targeted adjuvant treatment and perioperative immunotherapy ...
CheckMate-77T Update: Nivolumab-Based Regimen Improves EFS in NSCLC
PL02.08 Perioperative vs Neoadjuvant Nivolumab for Resectable NSCLC ...
CheckMate-77T: A Deeper Look at a Nivolumab-Based Regimen in NSCLC ...
日本人に対するニボルマブのNSCLC周術期治療（CheckMate 77T）／日本肺癌学会｜医師向け医療ニュースはケアネット
・第III相CheckMate 77T試験・・・切除可能非小細胞肺がんに対するニボルマブ併用周術期補助療法 - 大分で肺癌診療
Advances in the Treatment of Resectable NSCLC: Key Insights From ...
CheckMate-77T (Periop Nivolumab) vs. CheckMate-816 (Neoadj Nivolumab ...
Frontiers | Nivolumab adjuvant therapy for esophageal cancer: a review ...
DailyMed - OPDIVO- nivolumab injection
MA04.05 Patient-Reported Outcomes With Perioperative Nivolumab by Nodal ...
Updates in lung cancer - nsclc 2024 pptx | PPTX
CPCNP: nivolumab perioperatorio demuestra resultados favorables en SLE ...
FDA Approves Perioperative Nivolumab in Resectable NSCLC | Targeted ...
CheckMate-77T: Perioperative nivolumab benefit for NSCLC - YouTube
2025 ASCO：CheckMate 816/77T携两大LBA，试图解答能不能做“精准辅助治疗” ! - 100医药网
CheckMate-77T Update: Nivolumab-Based Regimen Improves EFS in NSCLC ...
Perioperative OPDIVO® (nivolumab) + Chemo Efficacy Data for Resectable ...
NSCLCへの周術期ニボルマブ追加、OS中間解析（CheckMate 77T）／ASCO2025｜医師向け医療ニュースはケアネット
Perioperative nivolumab (NIVO) vs placebo (PBO) in patients (pts) with ...
How perioperative nivolumab boosts EFS in NSCLC patients | Elvina ...
NSCLCへの周術期ニボルマブ上乗せ、術前療法が未完了でも有効か（CheckMate 77T）／ELCC2024｜医師向け医療ニュースはケアネット
Resultados clínicos com nivolumabe perioperatório (NIVO) conforme o ...
LBA50 Perioperative nivolumab (NIVO) v placebo (PBO) in patients (pts ...
ニボルマブベースの非小細胞肺がん周術期レジメンが有効性示す（CheckMate 77T）／ESMO2023｜医師向け医療ニュースはケアネット
FDA Approves Perioperative Nivolumab in Resectable NSCLC
CheckMate-77T ｜术前术后应用纳武利尤单抗降低 NSCLC 术后复发风险_凤凰网健康_凤凰网
Adding Perioperative Nivolumab to Neoadjuvant Chemotherapy in ...
Perioperative Nivolumab in Resectable Lung Cancer | New England Journal ...
Multimodal prediction of response to neoadjuvant nivolumab and ...
FDA Approves Nivolumab for the Treatment of Adult Patients With ...
CheckMate-77T vs. Checkmate-816: Nivolumabe perioperatório ou ...
CCMTV医学直播间
